secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibrx Biosciences, Inc. (INBX)
CIK:        0002007919
Form:       8-K
Filed at:   2026-02-23T23:59:59+00:00
Accession:  0002007919-26-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibrx publishes updated corporate presentation on investor website
--------------------------------------------------------------------

- Presentation posted February 23, 2026 under the Investors tab of www.inhibrx.com.
- Filing includes only presentation disclaimer; substantive pipeline and financial details not accessible in this report.
- Company routinely updates this presentation for conferences and meetings; no specific material changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2007919/000200791926000002/0002007919-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2007919/000200791926000002/inhibrx-20260223.htm
  HTML page:      https://secwatch.observer/filing/0002007919-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer